Longevity Health Holdings, Inc.
XAGE
$0.1246
-$0.004-3.11%
| Weiss Ratings | XAGE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | XAGE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | XAGE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.44 | |||
| Price History | XAGE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -5.53% | |||
| 30-Day Total Return | -46.98% | |||
| 60-Day Total Return | -76.56% | |||
| 90-Day Total Return | -58.76% | |||
| Year to Date Total Return | -82.00% | |||
| 1-Year Total Return | -94.92% | |||
| 2-Year Total Return | -98.77% | |||
| 3-Year Total Return | -98.71% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -95.61% | |||
| 52-Week Low % Change | 28.60% | |||
| Price | XAGE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $2.93 | |||
| 52-Week Low Price | $0.10 | |||
| 52-Week Low Price (Date) | Mar 28, 2025 | |||
| 52-Week High Price (Date) | May 23, 2024 | |||
| Valuation | XAGE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 3.87M | |||
| Enterprise Value | 4.36M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.48 | |||
| Earnings Per Share Growth | -93.46% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 53.58 | |||
| Price/Book (Q) | -0.57 | |||
| Enterprise Value/Revenue (TTM) | 86.59 | |||
| Price | $0.12 | |||
| Enterprise Value/EBITDA (TTM) | -0.89 | |||
| Enterprise Value/EBIT | -0.87 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | XAGE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 20.90M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | XAGE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 919 313 9633 | |||
| Address | 2403 Sidney Street Pittsburgh, PA 15203 | |||
| Website | www.carmellcosmetics.com | |||
| Country | United States | |||
| Year Founded | 2008 | |||
| Profitability | XAGE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -9,937.37% | |||
| Profit Margin | -20,612.92% | |||
| Management Effectiveness | XAGE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -9.55% | |||
| Return on Equity | -- | |||
| Income Statement | XAGE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 50.30K | |||
| Total Revenue (TTM) | 50.30K | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | 44.00K | |||
| EBITDA (TTM) | -4.92M | |||
| EBIT (TTM) | -5.00M | |||
| Net Income (TTM) | -10.37M | |||
| Net Income Avl. to Common (TTM) | -10.37M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -10,173.03% | |||
| EPS Diluted (TTM) | -0.48 | |||
| EPS Diluted Growth (Q YOY) | -132.49% | |||
| Balance Sheet | XAGE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 157.10K | |||
| Cash Per Share (Q) | $0.01 | |||
| Total Current Assets (Q) | 955.60K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -4.71M | |||
| Current Ratio (Q) | 0.163 | |||
| Book Value Per Share (Q) | -$0.23 | |||
| Total Assets (Q) | 1.47M | |||
| Total Current Liabilities (Q) | 5.88M | |||
| Total Debt (Q) | 639.00K | |||
| Total Liabilities (Q) | 6.19M | |||
| Total Common Equity (Q) | -4.71M | |||
| Cash Flow | XAGE - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -748.80K | |||
| Cash from Financing (TTM) | 2.38M | |||
| Net Change in Cash (TTM) | -2.76M | |||
| Levered Free Cash Flow (TTM) | 25.56M | |||
| Cash from Operations (TTM) | -4.39M | |||
